To compare perioperative morbidity and 1-year outcomes of older and younger women undergoing surgery for pelvic organ prolapse (POP immediately postoperatively, and 6 weeks and 3 and 12 months postoperatively). RESULTS: Three hundred twenty-two women aged 31 to 82 (21% aged !70), 93% white. Older women had higher baseline comorbidity (Po.001) and more severe POP (P 5.003). Controlling for prolapse stage and whether Burch was performed, there were no age differences in complication rates. Older women had longer hospital stays (3.1 AE 1.0 vs 2.7 AE 1.5 days, P 5.02) and higher prevalence of incontinence at 6 weeks (54.7% vs 37.2%, P 5.005). At 3 and 12 months, there were no differences in self-reported incontinence, stress testing for incontinence, or prolapse stage. Improvements from baseline were significant on all QOL measures but with no age differences. CONCLUSION: Outcomes of prolapse surgery were comparable between older and younger women except that older women had slightly longer hospital stays. J Am Geriatr Soc 55:857-863, 2007. Key words: surgery; pelvic organ prolapse; older women; outcomes; quality of life; length of stay P elvic floor disorders, including urinary incontinence, fecal incontinence, and pelvic organ prolapse (POP), increase in prevalence with age.
P elvic floor disorders, including urinary incontinence, fecal incontinence, and pelvic organ prolapse (POP), increase in prevalence with age. 1 As a result of increase in overall life expectancy, it is estimated that the number of women aged 85 and older will double to more than 6 million by 2030. 2 It is estimated that these demographic changes will cause the demand for pelvic floor medical services to rise at twice the rate of growth of the total population over the next 3 decades. Surgery, one of the most effective treatment modalities for POP, can be associated with significant complications, especially in older people. Before patients can be adequately counseled about surgical therapy, accurate age-specific data for efficacy and surgical morbidity are needed.
Despite the pressing need for surgical outcomes data in older patients, there is a relative paucity of such information in the literature. 3 In fact, older patients are often specifically excluded from clinical trials. One study reported that one-third of original research papers in major medical journals excluded elderly patients without justification. 4 The data that exist regarding surgical outcomes in older patients are somewhat mixed.
One study using data from the Nationwide Inpatient Sample of 264,340 patients reported that older women had a higher risk of morbidity and mortality after urogynecological surgery. 5 Similarly, in a retrospective review of 226 women undergoing surgery for incontinence at a large referral center, women aged 70 and older had a higher risk of complications than those younger than 70. 6 Conversely, a retrospective chart review of 267 patients aged 75 and older who underwent urogynecological surgery found a low overall perioperative morbidity rate, although preexisting cardiovascular disease increased the incidence of perioperative complications. 7 A study of 128 patients aged 80 and older who had surgery for POP concluded that the operative correction of POP had acceptable morbidity and a high satisfaction rate. 8 The purpose of this article is to compare perioperative morbidity and surgical and quality of life (QOL) outcomes at 6 weeks and 3 and 12 months in women aged 70 and older with those younger than 70 undergoing abdominal surgery for POP.
METHODS
This was a prospective ancillary analysis of the Colpopexy and Urinary Reduction (CARE) Study. The study was performed through the Pelvic Floor Disorders Network, a cooperative network sponsored by the National Institute of Child Health and Human Development. The methods and primary outcome of CARE have been reported previously. 9, 10 Briefly, women with Stage II, III, or IV prolapse 11 undergoing an abdominal sacrocolpopexy with no subjective evidence of urinary stress incontinence and sufficient urethral mobility for a Burch urethropexy were invited to participate in the study. The abdominal sacrocolpopexy was performed through a laparotomy incision, a laparoscopic approach was not allowed in this protocol. All women provided written informed consent to participate, and eligible women were enrolled between March 2002 and February 2005. On the day of surgery, study participants undergoing a sacrocolpopexy were randomized in the operating room to have or not have a concomitant Burch colposuspension procedure. Study participants and the research staff who performed the follow-up assessments were blinded to the treatment assignments for a minimum of 3 months and up to 3 years. For the outcome variables analyzed in this paper, the CARE population was dichotomized into women aged 70 and older and those younger than 70.
Objective assessments of POP and incontinence and symptom-specific and general QOL questionnaires were collected preoperatively and postoperatively at 6 weeks and 3 and 12 months. Objective assessment of prolapse was performed using the Pelvic Organ Prolapse Quantification Examination (POP-Q).
11 At baseline, a research nurse assessed preoperative urodynamics according to a study protocol with prolapse unreduced and then with prolapse reduced. Postoperatively, stress incontinence was measured objectively at 3 months using a standardized stress test at 300 ml or maximum capacity (whichever was less), in the sitting and then the standing position, using Valsalva or cough as the stress maneuver.
Women completed QOL questionnaires by telephone survey conducted by the Quality of Life Interviewing Center at the University of Michigan. Condition-specific QOL instruments included the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) for the assessment of pelvic symptoms and their effect on QOL. 12 The three subscales of the PFDI were analyzed separately: the Urinary Distress Inventory (28 items), the Colorectal-Anal Distress Inventory (17 items), and the Pelvic Organ Prolapse Distress Inventory (16 items). The three subscales of the PFIQ were also analyzed separately: the Incontinence Impact Questionnaire (31 items), the Colorectal-Anal Impact Questionnaire (31 items), and the Pelvic Organ Prolapse Impact Questionnaire (31 items).
General QOL was assessed using the 36-item Medical Outcomes Study Short-Form Health Survey (SF-36). 13 The SF-36 has two summary indexes, the Mental Component Summary (MCS) and the Physical Component Summary (PCS), which are derived from the weighted averages of the individual domain scores.
14 Sexual function was measured using the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire. 15 For all QOL measures, the median value of the subscale at baseline was calculated, as well as the mean change from baseline at each follow-up time point.
A comorbidity index, the Cumulative Illness Rating Scale (CIRS) 16 was used to quantitate the burden of chronic illness. Serious adverse events, defined as untoward medical occurrences that were life threatening or fatal or required prolonged hospitalization or readmission for the index surgery, any condition that resulted in persistent or clinically significant disability, or any other important medical condition that occurred in the immediate intra-or postoperative and short-term (6 weeks, 3 and 12 months) postoperative periods were recorded. A committee of three investigators reviewed serious adverse events and used consensus to group them by the affected organ system or as febrile illnesses, wound complications, or the need for a blood transfusion.
Demographic data collected at baseline included age, race, marital status, level of education, employment status, and insurance type. Baseline variables collected from past medical history included mode of delivery, use of hormone therapy, smoking status, previous treatments for urinary incontinence and POP, previous hysterectomy, and medical comorbidities (diabetes mellitus, coronary-vascular disease, and lung disease).
Data collected intraoperatively included whether a Burch procedure was performed and the length of the surgery. Immediate postoperative data collection included the length of hospital stay, blood transfusion (including intraoperative), wound complications, and febrile complications. In addition, any organ damage or cardiovascular, pulmonary, gastrointestinal, or neurological serious adverse events were noted. The need for an indwelling urinary catheter or performance of clean intermittent selfcatheterization and the number of days required for each were included in the postoperative outcomes. Leakage of urine postoperatively was defined as answering ''yes'' to any of the three questions on the PFDI stress incontinence subscale or stress incontinence observed on the bladder fill stress test. Also, a general self-report question ascertaining any urine leakage was asked at 6 weeks and 3 and 12 months postoperatively.
Analysis
At baseline, the two groups were compared using a twosample t test for continuous measures or the Fisher exact test or chi-square test for discrete variables. For outcome variables, a general linear model was fit to the continuous measures; age ( !70 vs o70) was included as an indicator variable, and the models included as covariates the baseline stage of POP and whether a Burch procedure was performed (i.e., all P-values for outcome measures were adjusted for POP stage and performance of Burch procedure). Because PFDI and PFIQ scores were not normally distributed, analyses were performed after a square root transformation. When the outcome measure was discrete (dichotomous), the Mantel-Haenszel statistic (a chi-square statistic) was computed after adjustment for POP and performance of the Burch procedure.
Although planned prospectively, this comparison was not a primary aim of the CARE study. The following calculations of power indicate the underlying differences between groups that can be tested with 80% power; they were not used to determine the sample size. With the sample size available for this analysis (255 women o70; 67 women !70), there was 80% power to differentiate between proportions of 0.05 and 0.17, between 0.10 and 0.25, between 0.20 and 0.38, and between 0.40 and 0.60 when testing at a 5% level of significance. Also, when the dependent measure is continuous, there is 80% power to identify a change of 0.4 standard deviations (an effect size of 0.4) when comparing the two groups at a 5% level of significance. Results are presented as mean AE standard deviation or n (%), and P-values without a correction for the number of tests performed.
RESULTS
Three hundred twenty-two women, ranging in age from 31 to 82, were enrolled. Twenty-one percent of participants were aged 70 and older, and 93% were white. Table 1 displays baseline characteristics for both groups. More older than younger women had had prior hysterectomy and previous prolapse surgery. Older women had higher baseline comorbidity based on CIRS score and were more likely to have Stage III or IV POP. There were no differences between cohorts in baseline urodynamics, subscales of the PFDI or PFIQ, or SF-36 MCS or PCS scores. Fifty-five percent of older women and 47% of younger women were randomized to Burch along with sacrocolpopexy (P 5.27). Table 2 shows common perioperative complications and utilization data for each group. There were no deaths up to 1 year and only three withdrawals from the study, all in women younger than 70. There were no differences by age group in any perioperative complication rates. Length of hospital stay was longer in the older women (3.1 AE 1.0 vs 2.7 AE 1.5 days, P 5.02). This difference remained significant after adjustment for baseline comorbidity (CIRS score) (P 5.04). Rehospitalization rates were virtually the same in both age groups during the first 6 weeks (older 7.5% vs younger 5.9%; P 5.66 after adjusting for baseline comorbidity). Rehospitalization rates between 6 weeks and 3 months were higher in older women but not statistically significant (4.5% vs 1.2%, P 5.12 after adjusting for baseline comorbidity). The most common reasons for rehospitalization were related to the surgery and included ileus and small bowel obstruction, pelvic infection, and mesh erosion. Other reasons for rehospitalization included chest pain, fever, hip fracture after fall, hypokalemia, and vitamin B 12 deficiency.
At 6 weeks, more older women reported leakage of urine (54.7% vs 37.2%, P 5.005), but at 3 months (Table 3) , there was no difference in self-report of urine leakage, incontinence rates by stress test, or prolapse stage.
There were significant improvements from baseline on all the QOL measures for both age groups, including symptom-specific QOL measures and improvements in the PCS and MCS scores of the SF-36, although there were no differences in the baseline to 3-month change scores between subjects aged 70 and older and those who were younger. At 12 months, there continued to be no differences between the two age groups in prolapse stage, self-report of any urine leakage, incontinence rates by stress test, or magnitude of QOL and symptom score changes from baseline (Table 4) .
DISCUSSION
Aging is associated with changes that can affect surgical outcomes. These include physiological, functional, and cognitive issues. 17, 18 As women are living longer, it is expected that there will be an increase in surgery for pelvic floor disorders, yet little information exists regarding perioperative complications and outcomes of elective gynecological pelvic floor surgery, especially with an abdominal approach, in older and younger women. This type of information can help doctors more effectively counsel all of their patients undergoing surgery for urinary incontinence and POP. Studies assessing the morbidity and mortality from gynecological surgery in older woman reveal minimal or no increase in mortality attributable to age alone but do indicate greater morbidity related to underlying comorbidities. 19, 20 Fewer studies compare perioperative outcomes between groups of older and younger women. Overall, short-term outcomes of abdominal surgery for significant POP were comparable between women aged 70 and older and those younger than 70. Older women had more subjective complaints of incontinence at 6 weeks but no difference at 3 and 12 months. The low prevalence of postoperative complications in both groups may reflect an inherent bias of surgeons to select patients with the likelihood of undergoing major elective surgery uneventfully, whereas the frailer women with POP may be offered nonsurgical treatments. This could be entirely appropriate, but further study of selection criteria, particularly age as a criterion, for successful pelvic surgery is needed. Despite this potential for bias, a strength of this study is that more than 10 surgeons in seven academic medical centers across the United States with potentially different individualized approaches to patient care recruited patients into the study. Therefore, the selection bias in this study should be generalizable, at least for gynecologists and urologists specializing in pelvic floor surgery in academic medical centers.
20,21
Older women did have a slightly longer length of stay. Length of hospital stay for surgery can have important implications for cost of care. The older women in this study were hospitalized approximately half a day longer than the younger women. Although this longer stay may not seem clinically important, the economic significance from a hospital and insurance payer point of view may be substantial. An analysis of Medicare data examining morbidity and mortality of continence surgery in older women 22 showed that, in 66,478 patients with a mean and median age of 71 (range 65-100), length of stay increased linearly with age. In this report, an analysis of comorbidities was performed to determine whether the presence of medical problems affected length of stay. The effect of the most common chronic comorbidities (hypertension, diabetes mellitus, chronic obstructive pulmonary disease, and dementia) did not significantly affect length of stay, whereas the presence of congestive heart failure slightly increased length of stay. In the current study, the age-related increase in length of stay was independent of comorbidity. Further exploration of factors associated with length of stay after surgery should include ascertaining the level of postdischarge supportive care needed at home. Such studies could lead to alternative models of transitional care that could reduce costs by shortening length of stay, such as a home health aide for a day or two after hospital discharge.
A strength of the study was use of multiple standardized outcome measures administered by trained investigators blinded to treatment group. The multisite design of the trial was another strength and increases overall generalizability, although the trial occurred primarily at academic tertiary referral centers, which limits generalizability. Another limitation of the study was that, despite a large sample size (N 5 322) for a surgical trial, only 67 of these women were aged 70 and older, which limits statistical power. Because the prevalence of POP increases with age, one would have expected more older women in the sample. It could be that the increasing prevalence of comorbidities in older women caused a selection bias by the surgeons, the referring physicians, or the women themselves toward nonsurgical POP treatment. Thus the sample of older women most likely had fewer comorbidities at baseline than the general population of older women with severe POP.
No geriatric-specific evaluations were collected before or after surgery, including functional or cognitive assessment parameters, although one previous study noted that this did not affect outcome when collected preoperatively. 23 Specifically, it was shown that a preoperative geriatric assessment did not result in differences in physical or mental health outcomes at 6 weeks or 6 months postoperatively as measured using the SF-36 in older women who underwent elective pelvic floor surgery. Patients were also not monitored specifically for postoperative delirium, a highly prevalent postoperative occurrence in older patients. 24 This study is one of a small number of studies that have examined the effect of age on the surgical treatment of pelvic floor disorders. The cohort of older women had similar outcomes to the younger cohort in terms of pelvic floor symptoms, physical examination parameters, and QOL. The older and younger cohorts had significantly better symptom-specific and general QOL after this surgery, with no significant age differences in the magnitude of this change. The similar outcomes and low complication rates seem to indicate that chronological age should not be an exclusion criterion for an abdominal approach to POP surgery. This is an important study considering the underrepresentation of older persons, and older women in particular, in randomized clinical trials. A review of 20 randomized clinical trials of surgery for stress incontinence 3 found that the median percentage of subjects aged 70 and older was 3.8%, which is remarkably disproportional to the number of older women undergoing these procedures. As the population ages and increasing numbers of older women are undergoing treatment for POP 25 and urinary stress incontinence, 26 it is imperative that barriers to the inclusion of older women in research on pelvic floor disorders be overcome.
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